Weaver Consulting Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-166
| Closed | -$19K | – | 916 |
|
|
2020
Q3 | $19K | Hold |
166
| – | – | 0.01% | 417 |
|
|
2020
Q2 | $19K | Buy |
166
+42
| +34% | +$4.81K | 0.01% | 397 |
|
|
2020
Q1 | $10K | Hold |
124
| – | – | 0.01% | 454 |
|
|
2019
Q4 | $10K | Hold |
124
| – | – | 0.01% | 501 |
|
|
2019
Q3 | $11K | Hold |
124
| – | – | 0.01% | 468 |
|
|
2019
Q2 | $11K | Hold |
124
| – | – | 0.01% | 448 |
|
|
2019
Q1 | $10K | Buy |
+124
| New | +$10K | ﹤0.01% | 952 |
|